Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
6 pending office actions • 4 art units • 5 examiners • 0 of 6 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
PureCircle Limited has 5 pending office actions in the Chemistry & Materials technology area. These matters are distributed across 4 distinct examiners and 4 distinct art units. The presence of 4 distinct art units for 5 actions suggests that the company's chemistry-related filings are being reviewed by several different specialized groups, which can lead to different examination experiences depending on the specific art unit's standards.
MORNHINWEG, JEFFREY P is the busiest examiner for the portfolio, overseeing 2 pending office actions. The remaining pending actions are handled by the other distinct examiners, as the portfolio involves 5 pending office actions and 4 distinct examiners. With 4 distinct examiners in total, the workload is relatively concentrated, as MORNHINWEG, JEFFREY P is responsible for a larger share of the pending actions than any other individual. Practitioners should be aware that this examiner's decisions will have a significant impact on the portfolio's current status.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (17%) |
| Double-patenting + other | 1 (17%) |
| Multi-statute (no §101) | 4 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MORNHINWEG, JEFFREY P | 2 | 36.7% | +32.2% |
| ZHENG, LI | 1 | 83.5% | +13.0% |
| TURNER, FELICIA C | 1 | 26.2% | +30.2% |
| BEKKER, KELLY JO | 1 | 16.8% | +35.1% |
| CHOWDHURY, IQBAL HOSSAIN | 1 | 73.6% | +57.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19187642 | Stevia Cultivar '320032' With Super High Rebaudioside A Content | ZHENG, LI | — |
| 16973283 | HIGH-PURITY STEVIOL GLYCOSIDES | MORNHINWEG, JEFFREY P | — |
| 15550075 | REBAUDIOSIDE M BIOSYNTHETIC PRODUCTION AND RECOVERY METHODS | TURNER, FELICIA C | — |
| 18294393 | FLAVOR MODIFYING COMPOSITION | BEKKER, KELLY JO | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18413708 | STEVIA EXTRACTS | MORNHINWEG, JEFFREY P | 71d |
| 19187642 | Stevia Cultivar '320032' With Super High Rebaudioside A Content | ZHENG, LI | — |
| 16973283 | HIGH-PURITY STEVIOL GLYCOSIDES | MORNHINWEG, JEFFREY P | — |
| 15550075 | REBAUDIOSIDE M BIOSYNTHETIC PRODUCTION AND RECOVERY METHODS | TURNER, FELICIA C | — |
| 18294393 | FLAVOR MODIFYING COMPOSITION | BEKKER, KELLY JO | — |
| 18061861 | HIGH-PURITY STEVIOL GLYCOSIDES | CHOWDHURY, IQBAL HOSSAIN | — |
| Art Unit | Apps |
|---|---|
| 1793 | 3 |
| 1662 | 1 |
| 1792 | 1 |
| 1656 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19187642 | Stevia Cultivar '320032' With Super High Rebaudioside A Content | ZHENG, LI | 1662 | §103§112Other | Non-Final OA | — | Pending | Apr 23, 2025 |
| 16973283 | HIGH-PURITY STEVIOL GLYCOSIDES | MORNHINWEG, JEFFREY P | 1793 | §102§103Other | Final Rejection | — | Pending | Dec 08, 2020 |
| 15550075 | REBAUDIOSIDE M BIOSYNTHETIC PRODUCTION AND RECOVERY METHODS | TURNER, FELICIA C | 1793 | §103§112 | Final Rejection | — | Pending | Aug 10, 2017 |
| 18294393 | FLAVOR MODIFYING COMPOSITION | BEKKER, KELLY JO | 1792 | §103§112 | Non-Final OA | — | Pending | Feb 01, 2024 |
| 18413708 | STEVIA EXTRACTS | MORNHINWEG, JEFFREY P | 1793 | §103Other | Final Rejection | 71d | Pending | Jan 16, 2024 |
| 18061861 | HIGH-PURITY STEVIOL GLYCOSIDES | CHOWDHURY, IQBAL HOSSAIN | 1656 | §102§103DP | Non-Final OA | — | Pending | Dec 05, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPureCircle Limited has 6 pending office actions as of October 2026, spread across 4 art units and 5 examiners.
Jeffrey P Mornhinweg has the most, with 2 of PureCircle Limited's pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
